|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
CN101346357B
(zh)
|
2005-10-25 |
2014-04-02 |
盐野义制药株式会社 |
氨基二氢噻嗪衍生物
|
|
JP5383483B2
(ja)
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
アルツハイマー症治療用医薬組成物
|
|
EP2689780A1
(en)
|
2007-04-24 |
2014-01-29 |
Shionogi & Co., Ltd. |
Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group
|
|
BRPI0906962B8
(pt)
*
|
2008-01-18 |
2021-05-25 |
Eisai R&D Man Co Ltd |
composto de aminodiidrotiazina fundido
|
|
KR101324426B1
(ko)
|
2008-06-13 |
2013-10-31 |
시오노기세야쿠 가부시키가이샤 |
β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
|
|
WO2010013794A1
(en)
*
|
2008-07-28 |
2010-02-04 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
|
WO2010038686A1
(ja)
*
|
2008-09-30 |
2010-04-08 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規な縮合アミノジヒドロチアジン誘導体
|
|
CN102186841A
(zh)
*
|
2008-10-22 |
2011-09-14 |
盐野义制药株式会社 |
具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
US8557826B2
(en)
|
2009-10-08 |
2013-10-15 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use
|
|
EP2485591B1
(en)
|
2009-10-08 |
2016-03-23 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2485920B1
(en)
|
2009-10-08 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
KR20120104570A
(ko)
|
2009-12-11 |
2012-09-21 |
시오노기세야쿠 가부시키가이샤 |
옥사진 유도체
|
|
US20120245155A1
(en)
*
|
2009-12-11 |
2012-09-27 |
Shionogi & Co., Ltd. |
Fused heterocyclic compound having amino group
|
|
KR101730937B1
(ko)
|
2010-06-09 |
2017-04-27 |
얀센 파마슈티카 엔.브이. |
베타-세크레타아제(ｂａｃｅ) 저해제로 유용한 5,6-디하이드로-2ｈ-[1,4]옥사진-3-일-아민 유도체
|
|
EP2634188A4
(en)
|
2010-10-29 |
2014-05-07 |
Shionogi & Co |
FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
|
|
CN103261199A
(zh)
|
2010-10-29 |
2013-08-21 |
盐野义制药株式会社 |
萘啶衍生物
|
|
BR112013015430A2
(pt)
|
2010-12-22 |
2016-09-20 |
Janssen Pharmaceutica Nv |
derivados de 5,6-diidro-imidazo[1,2-a]pirazin-8-ilamina úteis como inibidores de beta-secretase (bace)
|
|
GB201100181D0
(en)
*
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101140D0
(en)
*
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
SG191710A1
(en)
*
|
2011-01-21 |
2013-08-30 |
Eisai R&D Man Co Ltd |
Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
|
|
PH12013501805A1
(en)
|
2011-03-09 |
2013-11-18 |
Janssen Pharmaceutica Nv |
3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
|
|
US9145426B2
(en)
|
2011-04-07 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
CN103608345A
(zh)
|
2011-04-26 |
2014-02-26 |
盐野义制药株式会社 |
噁嗪衍生物和含有该噁嗪衍生物的bace1抑制剂
|
|
US8604024B2
(en)
|
2011-05-24 |
2013-12-10 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
WO2012162334A1
(en)
|
2011-05-24 |
2012-11-29 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
US8927535B2
(en)
*
|
2011-07-06 |
2015-01-06 |
Hoffman-La Roche Inc. |
Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
|
|
US9181236B2
(en)
|
2011-08-22 |
2015-11-10 |
Merck Sharp & Dohme Corp. |
2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
|
|
WO2013030713A1
(en)
|
2011-08-31 |
2013-03-07 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds
|
|
JO3143B1
(ar)
|
2012-04-03 |
2017-09-20 |
Lilly Co Eli |
مركبات تتراهيدرو بيرولو ثيازين
|
|
HUE030534T2
(hu)
|
2012-04-27 |
2017-05-29 |
Eisai R&D Man Co Ltd |
Eljárás 5-(difluormetil)pirazin-2-karbonsav elõállítására és elõállítási intermediere
|
|
JP6110937B2
(ja)
|
2012-05-04 |
2017-04-05 |
ファイザー・インク |
ＡＰＰ、ＢＡＣＥ１、およびＢＡＣＥ２の阻害剤としての複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
GB201212871D0
(en)
|
2012-07-20 |
2012-09-05 |
Eisai Ltd |
Novel compounds
|
|
CA2882389A1
(en)
|
2012-09-20 |
2014-03-27 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014065434A1
(en)
|
2012-10-24 |
2014-05-01 |
Shionogi & Co., Ltd. |
Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
|
|
HUE031764T2
(en)
*
|
2012-10-26 |
2017-07-28 |
Lilly Co Eli |
Tetrahydropyrrolothiazine derivatives as BACE inhibitors
|
|
JP2016502978A
(ja)
|
2012-12-11 |
2016-02-01 |
ファイザー・インク |
ＢＡＣＥ１の阻害剤としてのヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
EP2935256B1
(en)
|
2012-12-19 |
2018-01-24 |
Bristol-Myers Squibb Company |
4,6-diarylaminothiazines as bace1 inhibitors and their use for the reduction of beta-amyloid production
|
|
CA2893333C
(en)
|
2012-12-19 |
2017-10-24 |
Pfizer Inc. |
Carbocyclic-and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9309263B2
(en)
|
2013-01-29 |
2016-04-12 |
Amgen Inc. |
Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
|
|
CA2899938C
(en)
|
2013-02-12 |
2021-10-19 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
|
CA2897678A1
(en)
|
2013-02-13 |
2014-08-21 |
Pfizer Inc. |
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
JP6389830B2
(ja)
*
|
2013-03-01 |
2018-09-12 |
アムジエン・インコーポレーテツド |
ベータ−セクレターゼ阻害剤としてのパーフルオロ化５，６−ジヒドロ−４ｈ−１，３−オキサジン−２−アミン化合物および使用方法
|
|
JP6374889B2
(ja)
|
2013-03-08 |
2018-08-15 |
アムジエン・インコーポレーテツド |
β−セクレターゼ阻害剤としての過フッ素化シクロプロピル縮合１，３−オキサジン−２−アミン化合物、及び使用方法
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
WO2014198851A1
(en)
|
2013-06-12 |
2014-12-18 |
Janssen Pharmaceutica Nv |
4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2h)-one derivatives as inhibitors of beta-secretase (bace)
|
|
US9751886B2
(en)
|
2013-06-12 |
2017-09-05 |
Janssen Pharmaceutica Nv |
4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)
|
|
JO3318B1
(ar)
*
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
|
WO2015017407A1
(en)
|
2013-07-30 |
2015-02-05 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
|
|
AU2015245260A1
(en)
|
2014-04-10 |
2016-10-06 |
Pfizer Inc. |
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
|
|
US9550762B2
(en)
|
2014-08-08 |
2017-01-24 |
Amgen, Inc. |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
MA40941A
(fr)
|
2014-11-10 |
2017-09-19 |
H Lundbeck As |
2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
|
|
JO3458B1
(ar)
|
2014-11-10 |
2020-07-05 |
H Lundbeck As |
2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1
|
|
CR20170187A
(es)
|
2014-11-10 |
2018-02-01 |
H Lundbeck As |
2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer
|
|
ES2768823T3
(es)
|
2014-12-18 |
2020-06-23 |
Janssen Pharmaceutica Nv |
Derivados de 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2H-pirrol-5-amina útiles como inhibidores de beta-secretasa
|
|
AR103680A1
(es)
|
2015-02-23 |
2017-05-24 |
Lilly Co Eli |
Inhibidores selectivos de bace1
|
|
CA2977667C
(en)
|
2015-03-19 |
2019-08-20 |
Eli Lilly And Company |
Aminothiazine compounds useful as selective bace1 inhibitors
|
|
AR104241A1
(es)
|
2015-04-29 |
2017-07-05 |
Lilly Co Eli |
Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TW201717948A
(zh)
|
2015-08-10 |
2017-06-01 |
Ｈ 朗德貝克公司 |
包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療
|
|
WO2017025565A1
(en)
*
|
2015-08-12 |
2017-02-16 |
H. Lundbeck A/S |
2-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines as bace1 inhibitors
|
|
JP2018531889A
(ja)
|
2015-08-12 |
2018-11-01 |
ハー・ルンドベック・アクチエゼルスカベット |
Ｂａｃｅ１阻害剤としての２−アミノ−３−フルオロ−３−（フルオロメチル）−６−メチル−６−フェニル−３，４，５，６−テトラヒドロピリジン
|
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
|
|
WO2017051294A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
|
|
AU2016325665A1
(en)
|
2015-09-24 |
2018-03-08 |
Pfizer Inc. |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
|
|
JOP20170106A1
(ar)
*
|
2016-05-20 |
2017-11-20 |
Eli Lilly And Company |
مركبات تترا هيدرو فوروكسازين واستخداماتها كمثبطات bace1 انتقائية
|
|
CN109890828A
(zh)
*
|
2016-11-04 |
2019-06-14 |
詹森药业有限公司 |
4,4a,5,7-四氢-3H-呋喃并[3,4-b]吡啶基化合物
|
|
MX388697B
(es)
|
2016-12-15 |
2025-03-20 |
Amgen Inc |
Derivados de tiazina como inhibidores de beta-secretasa y metodos de uso.
|
|
EP3555086B1
(en)
|
2016-12-15 |
2021-09-01 |
Amgen Inc. |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
|
|
MX386618B
(es)
|
2016-12-15 |
2025-03-19 |
Amgen Inc |
Derivados de tiazina condensados con ciclopropilo como inhibidores de beta-secretasa y métodos de uso.
|
|
MA54101A
(fr)
|
2016-12-15 |
2021-10-27 |
Amgen Inc |
Dérivés de thiazine et d'oxazine bicycliques en tant qu'inhibiteurs de bêta-sécrétase et procédés d'utilisation
|
|
MA52722A
(fr)
|
2016-12-15 |
2021-04-14 |
Amgen Inc |
Dérivés d'oxazine en tant qu'inhibiteurs de bêta-sécrétase et procédés d'utilisation
|
|
US20190389882A1
(en)
*
|
2017-03-07 |
2019-12-26 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
MX2019010659A
(es)
*
|
2017-03-07 |
2019-10-21 |
Janssen Pharmaceutica Nv |
Inhibidores de beta secretasa.
|
|
WO2018162445A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
CA3051764A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
EA201992108A1
(ru)
*
|
2017-09-07 |
2020-01-27 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
EA201992076A1
(ru)
*
|
2017-09-07 |
2020-03-19 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
CN110590517A
(zh)
*
|
2019-09-24 |
2019-12-20 |
武汉嘉诺康医药技术有限公司 |
一种3，4-二羟基-2′-氯苯乙酮的制备方法
|